These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Low level CpG island promoter methylation predicts a poor outcome in adult T-cell acute lymphoblastic leukemia. Touzart A; Boissel N; Belhocine M; Smith C; Graux C; Latiri M; Lhermitte L; Mathieu EL; Huguet F; Lamant L; Ferrier P; Ifrah N; Macintyre E; Dombret H; Asnafi V; Spicuglia S Haematologica; 2020 Jun; 105(6):1575-1581. PubMed ID: 31537687 [TBL] [Abstract][Full Text] [Related]
28. T-lymphoblastic leukaemia/lymphoma with rosettes and gland-like structures. Yang Y; Juskevicius R Br J Haematol; 2020 Oct; 191(2):141. PubMed ID: 32634863 [No Abstract] [Full Text] [Related]
29. T-cell acute lymphoblastic leukemias express a unique truncated FAT1 isoform that cooperates with NOTCH1 in leukemia development. de Bock CE; Down M; Baidya K; Sweron B; Boyd AW; Fiers M; Burns GF; Molloy TJ; Lock RB; Soulier J; Taghon T; Van Vlierberghe P; Cools J; Holst J; Thorne RF Haematologica; 2019 May; 104(5):e204-e207. PubMed ID: 30514801 [No Abstract] [Full Text] [Related]
30. T cell receptor alpha-chain gene rearrangements in B-precursor leukemia are in contrast to the findings in T cell acute lymphoblastic leukemia. Comparative study of T cell receptor gene rearrangement in childhood leukemia. Hara J; Benedict SH; Mak TW; Gelfand EW J Clin Invest; 1987 Dec; 80(6):1770-7. PubMed ID: 3500187 [TBL] [Abstract][Full Text] [Related]
31. MiR-7 Functions as a Tumor Suppressor by Targeting the Oncogenes TAL1 in T-Cell Acute Lymphoblastic Leukemia. Sun H; Zhang Z; Luo W; Liu J; Lou Y; Xia S Technol Cancer Res Treat; 2020; 19():1533033820934130. PubMed ID: 32633635 [TBL] [Abstract][Full Text] [Related]
32. Small RNA-Seq Reveals Similar miRNA Transcriptome in Children and Young Adults with T-ALL and Indicates miR-143-3p as Novel Candidate Tumor Suppressor in This Leukemia. Dawidowska M; Maćkowska-Maślak N; Drobna-Śledzińska M; Kosmalska M; Jaksik R; Szymczak D; Jarmuż-Szymczak M; Sadowska-Klasa A; Wojtaszewska M; Sędek Ł; Wróbel T; Zaucha JM; Szczepański T; Lewandowski K; Giebel S; Witt M Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077521 [TBL] [Abstract][Full Text] [Related]
33. Practical Considerations for Using RNA Sequencing in Management of B-Lymphoblastic Leukemia: Malaysia-Singapore Acute Lymphoblastic Leukemia 2020 Implementation Strategy. Ni Chin WH; Li Z; Jiang N; Lim EH; Suang Lim JY; Lu Y; Chiew KH; Yin Kham SK; Zhi Oh BL; Tan AM; Ariffin H; Yang JJ; Eng-Juh Yeoh A J Mol Diagn; 2021 Oct; 23(10):1359-1372. PubMed ID: 34365011 [TBL] [Abstract][Full Text] [Related]
34. Early T-Cell Precursor Acute Lymphoblastic Leukemia in an Infant With an NRAS Q61R Mutation and Clinical Features of Juvenile Myelomonocytic Leukemia. Raikar SS; Scarborough JD; Sabnis H; Bergsagel J; Wu D; Cooper TM; Keller FG; Wood BL; Bunting ST Pediatr Blood Cancer; 2016 Sep; 63(9):1667-70. PubMed ID: 27145535 [TBL] [Abstract][Full Text] [Related]
35. The prognosis of CALM-AF10-positive adult T-cell acute lymphoblastic leukemias depends on the stage of maturation arrest. Ben Abdelali R; Asnafi V; Petit A; Micol JB; Callens C; Villarese P; Delabesse E; Reman O; Lepretre S; Cahn JY; Guillerm G; Berthon C; Gardin C; Corront B; Leguay T; Béné MC; Ifrah N; Leverger G; Dombret H; Macintyre E Haematologica; 2013 Nov; 98(11):1711-7. PubMed ID: 23831922 [TBL] [Abstract][Full Text] [Related]
36. Immature MEF2C-dysregulated T-cell leukemia patients have an early T-cell precursor acute lymphoblastic leukemia gene signature and typically have non-rearranged T-cell receptors. Zuurbier L; Gutierrez A; Mullighan CG; Canté-Barrett K; Gevaert AO; de Rooi J; Li Y; Smits WK; Buijs-Gladdines JG; Sonneveld E; Look AT; Horstmann M; Pieters R; Meijerink JP Haematologica; 2014 Jan; 99(1):94-102. PubMed ID: 23975177 [TBL] [Abstract][Full Text] [Related]
37. Ldb1 is required for Lmo2 oncogene-induced thymocyte self-renewal and T-cell acute lymphoblastic leukemia. Li L; Mitra A; Cui K; Zhao B; Choi S; Lee JY; Stamos DB; El-Khoury D; Warzecha C; Pfeifer K; Hardwick J; Zhao K; Venters B; Davé UP; Love PE Blood; 2020 Jun; 135(25):2252-2265. PubMed ID: 32181817 [TBL] [Abstract][Full Text] [Related]
38. A comprehensive catalog of LncRNAs expressed in T-cell acute lymphoblastic leukemia. Kermezli Y; Saadi W; Belhocine M; Mathieu EL; Garibal MA; Asnafi V; Aribi M; Spicuglia S; Puthier D Leuk Lymphoma; 2019 Aug; 60(8):2002-2014. PubMed ID: 30648438 [TBL] [Abstract][Full Text] [Related]
39. Long noncoding RNA signatures define oncogenic subtypes in T-cell acute lymphoblastic leukemia. Wallaert A; Durinck K; Van Loocke W; Van de Walle I; Matthijssens F; Volders PJ; Avila Cobos F; Rombaut D; Rondou P; Mestdagh P; Vandesompele J; Poppe B; Taghon T; Soulier J; Van Vlierberghe P; Speleman F Leukemia; 2016 Sep; 30(9):1927-30. PubMed ID: 27168467 [No Abstract] [Full Text] [Related]
40. Optimized outcome prediction of oncogenetic mutations in non-early T-cell precursor acute lymphoblastic leukemia. Peng LJ; Wang SS; Guo SS; Zhang JJ; Liu YF; Rousseaux S; Khochbin S; Chen B; Wang J; Mi JQ Immunobiology; 2022 May; 227(3):152205. PubMed ID: 35279479 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]